Cellromax Science Co

Cellromax Science Co EBIT per Share

The EBIT per Share of Cellromax Science Co (471820.KQ) as of Oct 11, 2026 is 253.96 KRW. In the previous year, EBIT per Share was 489.47 KRW — a change of -48.12% (lower).

EBIT per Share

253.96KRW

YoY

-48.12%

Last updated:

EBIT per Share of Cellromax Science Co is 2025 253.96 KRW. EBIT per Share of Cellromax Science Co was 2024 489.47 KRW. It decreases by -48.12% lower compared to the previous year.

The Cellromax Science Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2022
573.60 KRW
Jan 1, 2023
400.83 KRW
Jan 1, 2024
489.47 KRW
Jan 1, 2025
253.96 KRW
The Cellromax Science Co EBIT per Share history
YEAREBIT per ShareYoY
253.96KRW-48.12%
489.47KRW+22.12%
400.83KRW-30.12%
573.60KRW—
Access this data via the Eulerpool API
Get Free API Key

Cellromax Science Co Stock analysis

What does Cellromax Science Co do? Cellromax Science Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cellromax Science Co stock

EBIT per Share of Cellromax Science Co is 253.96 KRW in 2025.

EBIT per Share of Cellromax Science Co changed from 489.47 KRW to 253.96 KRW, representing a -48.12% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Cellromax Science Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Cellromax Science Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Cellromax Science Co